Core Viewpoint - Wok Medical (WOK) experienced a stock price increase of 4.8% on August 20, 2023, closing at $0.83 per share, with a total market capitalization of $46.92 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.5064 million, representing a year-over-year decrease of 15.18% [1] - The company's net profit attributable to shareholders was -$3.4923 million, reflecting a significant year-over-year decline of 3217.31% [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables, including anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced plastic injection, extrusion molding, and packaging sealing equipment [1]

Core Viewpoint - Wok Medical (WOK) experienced a stock price increase of 3.72% on August 18, reaching $0.8 per share, with a total market capitalization of $45.23 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.51 million, representing a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.49 million, which is a significant decline of 3217.31% year-over-year [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced plastic injection, extrusion molding, and packaging sealing equipment [1]

Core Viewpoint - Wok Medical (WOK) experienced a 2.5% increase in stock price, reaching $0.8 per share, with a total market capitalization of $45.23 million as of August 14 [1] Financial Performance - For the fiscal year ending September 30, 2024, Wok Medical reported total revenue of $11.51 million, reflecting a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.49 million, which represents a significant year-over-year decline of 3217.31% [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a Cayman Islands-registered holding company that primarily operates through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables, including anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced plastic injection, extrusion molding, and packaging sealing equipment [1]

Core Viewpoint - Wok Medical (WOK) experienced a stock price increase of 3.24% on August 6, reaching $0.793 per share, with a total market capitalization of $44.83 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.51 million, representing a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to shareholders of -$3.49 million, which is a significant decline of 3217.31% year-over-year [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced equipment for plastic injection, extrusion molding, and packaging sealing [1]

Core Viewpoint - Wok Medical (WOK) experienced a significant stock price increase of 10.66% on August 5, reaching $0.85 per share, with a total market capitalization of $48.05 million [1] Financial Performance - As of September 30, 2024, Wok Medical reported total revenue of $11.5064 million, reflecting a year-over-year decrease of 15.18% [1] - The company recorded a net profit attributable to the parent of -$3.4923 million, which represents a staggering year-over-year decline of 3217.31% [1] Company Overview - Wok Medical Technology Group Co., Ltd. is a foreign holding company registered in the Cayman Islands, primarily operating through its domestic subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. [1] - The subsidiary, established in April 2002, specializes in the production of medical consumables such as anesthesia, respiratory, emergency, ICU, interventional products, and masks, utilizing advanced equipment for plastic injection, extrusion molding, and packaging sealing [1]

Core Insights - The company reported a revenue of 745 million yuan for the first half of 2025, representing a year-on-year growth of 10.19% [1] - The net profit attributable to shareholders reached 121 million yuan, with a year-on-year increase of 14.17% [1] Company Overview - The company, Weili Medical, specializes in the research, production, and sales of medical devices in various fields including anesthesia, catheterization, urology, nursing, respiratory care, and blood dialysis [1] - Its products are widely used in clinical settings for general open surgeries, minimally invasive surgeries, emergency care, and nursing [1]

资料显示，沃氪医疗科技集团有限公司是一家在开曼群岛注册成立的境外控股母公司,主要通过其境内 实体子公司杭州山友医疗器械有限公司运营。其子公司成立于2002年4月,是一家专业生产麻醉、呼吸、 急救、ICU、介入、口罩等医疗消耗品的企业,先后引进国内外先进的塑料注塑、挤塑成形、包装封口等 专业设备。 本文源自：金融界 作者：行情君 7月29日，沃氪医疗(WOK)开盘上涨4.29%，截至21:30，报0.85美元/股，成交108.0美元，总市值4805.44 万美元。 财务数据显示，截至2024年09月30日，沃氪医疗收入总额1150.64万美元，同比减少15.18%；归母净利 润-349.23万美元，同比减少3217.31%。 ...